The Roadmap of Colorectal Cancer Screening
Open Access
- 4 March 2021
- Vol. 13 (5), 1101
- https://doi.org/10.3390/cancers13051101
Abstract
Colorectal cancer (CRC) is the third most common form of cancer in terms of incidence and the second in terms of mortality worldwide. CRC develops over several years, thus highlighting the importance of early diagnosis. National screening programs based on fecal occult blood tests and subsequent colonoscopy have reduced the incidence and mortality, however improvements are needed since the participation rate remains low and the tests present a high number of false positive results. This review provides an overview of the CRC screening globally and the state of the art in approaches aimed at improving accuracy and participation in CRC screening, also considering the need for gender and age differentiation. New fecal tests and biomarkers such as DNA methylation, mutation or integrity, proteins and microRNAs are explored, including recent investigations into fecal microbiota. Liquid biopsy approaches, involving novel biomarkers and panels, such as circulating mRNA, micro- and long-non-coding RNA, DNA, proteins and extracellular vesicles are discussed. The approaches reported are based on quantitative PCR methods that could be easily applied to routine screening, or arrays and sequencing assays that should be better exploited to describe and identify candidate biomarkers in blood samples.Keywords
This publication has 141 references indexed in Scilit:
- Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control studyJournal of Experimental & Clinical Cancer Research, 2013
- Circulating nucleic acids in plasma and serum (CNAPS): applications in oncologyOncoTargets and Therapy, 2013
- European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – OrganisationEndoscopy, 2012
- Fecal DNA for Noninvasive Diagnosis of Colorectal Cancer in Immunochemical Fecal Occult Blood Test–Positive IndividualsCancer Epidemiology, Biomarkers & Prevention, 2010
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancerInternational Journal of Cancer, 2010
- A blood‐based biomarker panel for stratifying current risk for colorectal cancerInternational Journal of Cancer, 2009
- CEACAMs: their role in physiology and pathophysiologyCurrent Opinion in Cell Biology, 2006
- Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal TumorsScience, 1992
- Genetic Alterations during Colorectal-Tumor DevelopmentThe New England Journal of Medicine, 1988
- Diagnosis of Large-Bowel Cancer in the Asymptomatic PatientJAMA, 1967